RYVU THERAPEUTICS S A has a total of 13 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EFFECTOR THERAPEUTICS INC, SUZHOU KINTOR PHARMACEUTICALS INC and FURET PASCAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Fabritius Charles-Henry | 7 |
#2 | Galezowski Michal | 6 |
#3 | Radzimierski Adam | 6 |
#4 | Nowogrodzki Marcin | 5 |
#5 | Wronowski Marek | 5 |
#6 | Obara Alicja | 5 |
#7 | Swirski Mateusz | 5 |
#8 | Zastawna Magdalena | 5 |
#9 | Reus Jacek | 5 |
#10 | Porter Roderick Alan | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020249773A1 | Next-generation modulators of stimulator of interferon genes (sting) | |
WO2020128036A1 | Modulators of the adenosine a2a receptor | |
WO2019238786A1 | Modulators of stimulator of interferon genes (sting) | |
EP3699301A1 | Novel recql4 muteins and personalized treatment of glioblastoma patients | |
US2020369665A1 | Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor |